特维斯生物科学

最新新闻

• 评级变动
  Piper Sandler Maintains Twist Bioscience(TWST.US) With Buy Rating, Raises Target Price to $115
  \u5e02\u573a\u8d44\u8baf · 2026/8/5
• Guggenheim Maintains Twist Bioscience(TWST.US) With Buy Rating, Raises Target Price to $212
  \u5e02\u573a\u8d44\u8baf · 2026/10/1
• Barclays Maintains Twist Bioscience(TWST.US) With Buy Rating, Raises Target Price to $215
  \u5e02\u573a\u8d44\u8baf · 2026/10/7
• 评级变动
  William Blair Maintains Twist Bioscience(TWST.US) With Buy Rating
  \u5e02\u573a\u8d44\u8baf · 2026/8/4
• 评级变动
  Leerink Partners Maintains Twist Bioscience(TWST.US) With Buy Rating, Maintains Target Price $110
  \u5e02\u573a\u8d44\u8baf · 2026/7/17
• 评级变动
  Barclays Maintains Twist Bioscience(TWST.US) With Buy Rating, Raises Target Price to $95
  \u5e02\u573a\u8d44\u8baf · 2026/6/24
• 评级变动
  TD Cowen Maintains Twist Bioscience(TWST.US) With Buy Rating, Raises Target Price to $115
  \u5e02\u573a\u8d44\u8baf · 2026/8/4
• 评级变动
  Leerink Partners Maintains Twist Bioscience(TWST.US) With Buy Rating, Raises Target Price to $110
  \u5e02\u573a\u8d44\u8baf · 2026/7/16
• 评级变动
  CCORF Maintains Twist Bioscience(TWST.US) With Buy Rating, Maintains Target Price $120
  \u5e02\u573a\u8d44\u8baf · 2026/8/4
• 评级变动
  Evercore Downgrades Twist Bioscience(TWST.US) to Hold Rating, Raises Target Price to $102
  \u5e02\u573a\u8d44\u8baf · 2026/7/6
• 评级变动
  Baird Maintains Twist Bioscience(TWST.US) With Buy Rating, Raises Target Price to $115
  \u5e02\u573a\u8d44\u8baf · 2026/8/4
• 评级变动
  Leerink Partners Maintains Twist Bioscience(TWST.US) With Buy Rating, Raises Target Price to $160
  \u5e02\u573a\u8d44\u8baf · 2026/9/17
• Twist Bioscience(TWST.US) Officer Sells US$56.33 Million in Common Stock
  \u5e02\u573a\u8d44\u8baf · 2026/9/22
• 评级变动
  BWS Financial Initiates Twist Bioscience(TWST.US) With Sell Rating, Announces Target Price $45
  \u5e02\u573a\u8d44\u8baf · 2026/9/10
• Leerink Partners Maintains Twist Bioscience(TWST.US) With Buy Rating, Raises Target Price to $190
  \u5e02\u573a\u8d44\u8baf · 2026/9/29
• Trade.xyz announces the listing of synthetic DNA company TWST.
  Latest · 2026/10/8
• 评级变动
  Guggenheim Maintains Twist Bioscience(TWST.US) With Buy Rating, Raises Target Price to $107
  \u5e02\u573a\u8d44\u8baf · 2026/6/29
• 评级变动
  BWS Financial Maintains Twist Bioscience(TWST.US) With Sell Rating, Maintains Target Price $45
  \u5e02\u573a\u8d44\u8baf · 2026/9/18
• 评级变动
  CCORF Maintains Twist Bioscience(TWST.US) With Buy Rating, Raises Target Price to $120
  \u5e02\u573a\u8d44\u8baf · 2026/7/14
• 评级变动
  TD Cowen Maintains Twist Bioscience(TWST.US) With Buy Rating, Raises Target Price to $89
  \u5e02\u573a\u8d44\u8baf · 2026/6/15
• Form 144 | Twist Bioscience(TWST.US) Officer Proposes to Sell 44.68 Million in Common Stocks
  \u5e02\u573a\u8d44\u8baf · 2026/9/18
• Form 144 | Twist Bioscience(TWST.US) Officer Proposes to Sell 9.31 Million in Common Stocks
  \u5e02\u573a\u8d44\u8baf · 2026/9/18
• 评级变动
  CCORF Initiates Twist Bioscience(TWST.US) With Buy Rating, Announces Target Price $90
  \u5e02\u573a\u8d44\u8baf · 2026/6/15

新闻标题为自动聚合内容，未经我们团队独立核实或编辑。